| Primary |
| Pain |
66.7% |
| Lymphoma |
33.3% |
|
|
| Secondary |
| Pain Management |
33.3% |
| Migraine |
25.0% |
| Cardiac Disorder |
12.5% |
| Diabetes Mellitus |
8.3% |
| Drug Use For Unknown Indication |
8.3% |
| Pain |
8.3% |
| Atrial Fibrillation |
4.2% |
|
| Pruritus |
25.0% |
| Withdrawal Syndrome |
25.0% |
| Wound Secretion |
25.0% |
| Fatigue |
12.5% |
| Spinal Epidural Haemorrhage |
12.5% |
|
| Concomitant |
| Pain |
13.0% |
| Prophylaxis |
11.5% |
| Anxiety |
10.2% |
| Back Pain |
10.2% |
| Product Used For Unknown Indication |
7.9% |
| Drug Use For Unknown Indication |
6.9% |
| Dyspnoea |
6.3% |
| Hypertension |
5.6% |
| Infection Prophylaxis |
4.8% |
| Acute Myocardial Infarction |
3.9% |
| Plasma Cell Myeloma |
2.5% |
| Nausea |
2.3% |
| Insomnia |
2.1% |
| Thrombosis Prophylaxis |
2.1% |
| Infection |
1.9% |
| Constipation |
1.9% |
| Neutropenia |
1.9% |
| Neutrophil Count Decreased |
1.9% |
| Chronic Obstructive Pulmonary Disease |
1.7% |
| Hiv Infection |
1.7% |
|
| Pneumonia |
16.7% |
| Renal Colic |
11.1% |
| Pneumothorax |
6.7% |
| Gastrointestinal Haemorrhage |
5.6% |
| Hypomagnesaemia |
5.6% |
| Pulmonary Embolism |
5.6% |
| Pyrexia |
5.6% |
| Fatigue |
4.4% |
| Sarcoma |
4.4% |
| Spinal Compression Fracture |
4.4% |
| Tumour Flare |
4.4% |
| Dystonia |
3.3% |
| International Normalised Ratio Increased |
3.3% |
| Malignant Neoplasm Progression |
3.3% |
| Osteonecrosis |
3.3% |
| Renal Failure Acute |
3.3% |
| Asthma |
2.2% |
| Death |
2.2% |
| Foot Fracture |
2.2% |
| Hypertension |
2.2% |
|
| Interacting |
| Pain |
40.0% |
| Atrial Fibrillation |
20.0% |
| Lymphoma |
20.0% |
| Product Used For Unknown Indication |
20.0% |
|
| Spinal Epidural Haemorrhage |
50.0% |
| Vomiting |
50.0% |
|
